Table 5 Baseline characteristics of the subgroup analysis patients.
Project | Total gastrectomy CG (N = 20) | Total gastrectomy EG (N = 20) | P-valuea | Partial gastrectomy CG (N = 17) | Partial gastrectomy EG (N = 21) | P-valuea |
|---|---|---|---|---|---|---|
Sex (Male/Female) | 12/8 | 14/6 | 0.507 | 10/7 | 14/7 | 0.618 |
Age | 60.30 ± 10.92 | 58.75 ± 11.51 | 0.665 | 56.35 ± 8.21 | 54.74 ± 13.36 | 0.640 |
BMI (kg/m2) | ||||||
< 18.5 | 0 | 0 | 1.000 | 0 | 0 | 0.491 |
18.5–24 | 10 | 10 | 11 | 16 | ||
> 24 | 10 | 10 | 6 | 5 | ||
NRS 2002 (score) | ||||||
< 3 | 10 | 11 | 0.752 | 10 | 9 | 0.328 |
≥ 3 | 10 | 9 | 7 | 12 | ||
PG-SGA (score) | ||||||
< 4 | 5 | 1 | 0.184 | 4 | 5 | 1.000 |
≥ 4 | 15 | 19 | 13 | 16 | ||
Tumor staging | ||||||
Stage Ⅰ | 4 | 1 | 0.180 | 9 | 10 | 0.449 |
Stage Ⅱ and Stage Ⅲ | 16 | 18 | 8 | 9 | ||
Stage Ⅳ | 0 | 1 | 0 | 2 | ||
